ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025
(NASDAQ:ICCC), PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended June 30, […]